CompletedNCT01527448
Quetiapine for Postpartum Depression Related to Bipolarity
About this title
Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II
Read the official source — NCT01527448Medication studyAges 19–40Canada
Understand this study
Who was this study for?
Listed age limits: 19 years to 40 years.
- Listed locations
- VancouverSee all locations and recruitment
Study information
Study start dateApril 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 26
- Sponsor
- BC Women's Hospital & Health Centre
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 19 Years to 40 Years
- Official registry ID
- NCT01527448
- Official title
Show the full official title
An Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is BC Women's Hospital & Health Centre, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine XR (seroquel).
Who was this study for?
Listed age limits: 19 years to 40 years.
